We are live on ! Find out more
WAM

Wolverine Asset Management Portfolio holdings

AUM $10.4B
1-Year Est. Return 4.78%
This Fund
S&P 500
This Quarter Est. Return
+1.31%
1 Year Est. Return
+4.78%
3 Year Est. Return
+13.26%
5 Year Est. Return
+14.27%
10 Year Est. Return
+63.71%
AUM
$9.66B
AUM Growth
+$381M
Cap. Flow
-$3.73B
Cap. Flow %
-38.65%
Top 10 Hldgs %
13.55%
Holding
2,891
New
373
Increased
561
Reduced
522
Closed
787

Top Buys

Rank Stock Value
1
QCOM icon
Qualcomm
QCOM
+$34.6M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$16.2M
3
AVGO icon
Broadcom
AVGO
+$15.3M
4
UGIC
UGI Corporation
UGIC
+$9.02M
5
KBR icon
KBR
KBR
+$8.71M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$20.1M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$19.2M
3
SWT
Stanley Black & Decker, Inc.
SWT
+$16.1M
4
HTAQ
Hunt Companies Acquisition Corp. I
HTAQ
+$10.1M
5
META icon
Meta Platforms (Facebook)
META
+$9.56M

Sector Composition

Rank Sector Weight
1 Financials 4.28%
2 Technology 3.28%
3 Industrials 1.3%
4 Healthcare 1.22%
5 Consumer Discretionary 1.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LGHLW
1626
DELISTED
Lion Group Holding Ltd. Warrant
LGHLW
$4.51K ﹤0.01%
112,729
+12,019
+12% +$663
SRZN icon
1627
Surrozen
SRZN
$251M
$4.5K ﹤0.01%
515
-67
-12% -$1.42K
IRRX.WS
1628
DELISTED
Integrated Rail and Resources Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
IRRX.WS
$4.43K ﹤0.01%
31,682
-82,181
-72% -$11K
CANO
1629
DELISTED
Cano Health, Inc.
CANO
$4.33K ﹤0.01%
32
-1,466
-98% -$496K
ZFOXW
1630
DELISTED
ZeroFox Holdings, Inc. Warrants
ZFOXW
$4.3K ﹤0.01%
28,370
+4,718
+20% +$698
MCACR
1631
DELISTED
Monterey Capital Acquisition Corporation Rights
MCACR
$4.29K ﹤0.01%
45,209
– –
FXCOW
1632
DELISTED
Financial Strategies Acquisition Corp. Warrants
FXCOW
$4.26K ﹤0.01%
213,284
– –
SCUA.WS
1633
DELISTED
Sculptor Acquisition Corp I Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
SCUA.WS
$4.25K ﹤0.01%
82,118
– –
CLDI.WS
1634
DELISTED
Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00
CLDI.WS
$4.23K ﹤0.01%
84,581
– –
PEARW
1635
DELISTED
Pear Therapeutics, Inc. Warrant
PEARW
$4.2K ﹤0.01%
28,199
-3,786
-12% -$605
NNAVW
1636
DELISTED
NextNav Inc Warrant
NNAVW
$4.15K ﹤0.01%
11,142
+4,624
+71% +$2.91K
ALVOW icon
1637
Alvotech Warrant
ALVOW
$4.04K ﹤0.01%
4,345
+3,145
+262% +$2.18K
RRAC
1638
DELISTED
Rigel Resource Acquisition Corp.
RRAC
$3.96K ﹤0.01%
+385
New +$3.92K
PERF.WS
1639
DELISTED
Perfect Corp Warrants
PERF.WS
$3.85K ﹤0.01%
+25,066
New +$4.92K
ENVA icon
1640
PUT
Enova International
ENVA
$6.37B
$3.84K ﹤0.01%
100
– –
DBD
1641
PUT
DELISTED
Diebold Nixdorf Incorporated
DBD
$3.83K ﹤0.01%
2,700
-31,800
-92% -$68.2K
CEROW
1642
DELISTED
CERo Therapeutics Warrants
CEROW
$3.79K ﹤0.01%
87,893
+7,204
+9% +$379
IONS icon
1643
PUT
Ionis Pharmaceuticals
IONS
$9.06B
$3.78K ﹤0.01%
100
– –
BTMDW
1644
DELISTED
Biote Corp. Warrant
BTMDW
$3.77K ﹤0.01%
12,571
+4,510
+56% +$1.23K
BMAC.WS
1645
DELISTED
Black Mountain Acquisition Corp. Warrants, exercisable for one share of Class A Common Stock
BMAC.WS
$3.71K ﹤0.01%
101,175
– –
ILLRW
1646
Triller Group Inc Warrant
ILLRW
$3.71K ﹤0.01%
+87,525
New +$4.68K
BOCNW
1647
DELISTED
Blue Ocean Acquisition Corp Warrants
BOCNW
$3.7K ﹤0.01%
49,314
– –
KCGI.WS
1648
DELISTED
Kensington Capital Acquisition Corp. V Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
KCGI.WS
$3.69K ﹤0.01%
21,732
-40,173
-65% -$5.83K
ZCARW
1649
DELISTED
Zoomcar Holdings, Inc. Warrants
ZCARW
$3.67K ﹤0.01%
145,764
-40,236
-22% -$2.28K
GRND.WS
1650
DELISTED
Grindr Inc. Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share
GRND.WS
$3.66K ﹤0.01%
+7,634
New +$4.51K
64 65
66
67 68

Similar funds

PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
VPIM
Vanguard Personalized Indexing Management Oakland, California $10.2B AUM 34.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
IIM
INTECH Investment Management West Palm Beach, Florida $10.2B AUM 28.14% 1-Year Est. Return
GI
GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
SGA
Sustainable Growth Advisers Stamford, Connecticut $10.6B AUM 2.6% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Wolverine Asset Management's Q4 2022 Portfolio in Review

As of Q4 2022, Wolverine Asset Management held 2,891 positions worth $9.66B, up 4.1% from $9.28B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Wolverine Asset Management withdrew a net $3.73B in Q4 2022, closing 787 positions and reducing 522 holdings. Its most notable exit was Stanley Black & Decker, Inc., an estimated $16.1M position sold in full.

By sector, the portfolio is most concentrated in Financials at 4.3% of assets, down from 5.9% a quarter earlier, followed by Technology and Industrials.

Against the trend, Wolverine Asset Management opened a new position in Alphabet (Google) Class C worth $15.1M.

  • Wolverine Asset Management's largest Q4 2022 buy was Alphabet (Google) Class C: 170,209 shares worth $15.1M.
  • Wolverine Asset Management added most to Qualcomm in Q4 2022, an estimated $34.6M increase.
  • Wolverine Asset Management's biggest Q4 2022 reduction was Microsoft, cutting an estimated $20.1M.
  • Wolverine Asset Management fully exited Stanley Black & Decker, Inc. in Q4 2022, selling an estimated $16.1M.
  • Wolverine Asset Management's ten largest holdings make up 14% of its $9.66B portfolio in Q4 2022.
  • Wolverine Asset Management opened 373 new positions and closed 787 in Q4 2022.
  • Wolverine Asset Management's portfolio value rose 4.1% quarter-over-quarter to $9.66B.

Based on Wolverine Asset Management's 13F filing for Q4 2022, filed 1 Feb 2023.